Showing results (51-60 of 591) with videos related to
Sort By:
Pageof 60
Antiviral Research|July 4, 2021
Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analoguesLeentje Persoons, Evelien Vanderlinden, Laura Vangeel, et al.Antiviral Research|March 5, 2003
Therapy and short-term prophylaxis of poxvirus infections: historical background and perspectivesJohan Neyts, Erik De ClercqReviews in Medical Virology|August 31, 2004
Therapeutic potential of nucleoside/nucleotide analogues against poxvirus infectionsErik De Clercq, Johan NeytsCurrent Opinion in Pharmacology|July 2, 2016
Towards antiviral therapies for treating dengue virus infectionsSuzanne Jf Kaptein, Johan NeytsTrends in Pharmacological Sciences|May 8, 2007
Avian influenza A (H5N1) infection: targets and strategies for chemotherapeutic interventionErik De Clercq, Johan NeytsAntimicrobial Agents and Chemotherapy|May 21, 2014
Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell cultureAdriaan H de Wilde, Dirk Jochmans, Clara C Posthuma, et al.Antiviral Research|June 29, 2021
A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agentsThuc Nguyen Dan Do, Kim Donckers, Laura Vangeel, et al.Molecular Diversity|October 17, 2022
Synthesis of new 3-acetyl-1,3,4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agentsSaida Lachhab, Az-Eddine El Mansouri, Ahmad Mehdi, et al.European Journal of Medicinal Chemistry|May 7, 2021
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptorsMaria Chiara Pismataro, Tommaso Felicetti, Chiara Bertagnin, et al.Antiviral Research|October 14, 2023
Anti-SARS-CoV-2 activity of cyanopeptolins produced by Nostoc edaphicum CCNP1411Robert Konkel, Aleksandra Milewska, Nguyen Dan Thuc Do, et al.Pageof 60